SM Energy (NYSE:SM – Get Free Report) was upgraded by stock analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Friday,Finviz reports. The brokerage presently has a $40.00 price objective on the energy company’s stock. JPMorgan Chase & Co.‘s price objective would […]

Nomura (NYSE:NMR – Get Free Report) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Thursday,Benzinga reports. Separately, Weiss Ratings restated a “hold (c)” rating on shares of Nomura in a research note on Monday, December 29th. […]

CytomX Therapeutics (NASDAQ:CTMX – Get Free Report) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a report released on Monday, Marketbeat reports. The brokerage presently has a $12.00 target price on the biotechnology company’s stock, up from their previous target price of $7.00. JPMorgan Chase […]

Cognex (NASDAQ:CGNX – Get Free Report) was upgraded by JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating in a report released on Monday, MarketBeat Ratings reports. The firm presently has a $55.00 price target on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s target price would indicate a […]